Absolute Bioavailability and ADME study of [14C]AZD9977 in Healthy Male Subjects

Trial Identifier: D6402C00002
Sponsor: AstraZeneca
Quotient Sciences Limited
NCTID:: NCT04686591
Start Date: December 2020
Primary Completion Date: February 2021
Study Completion Date: February 2021
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
GB Ruddington, GB, NG11 6JS